Skip to main content

Concepció Jacobs Cachá

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Concepció Jacobs Cachá

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Research lines

Estudi de les bases biològiques de patologies glomerulars o sistèmiques amb directe afectació renal com la nefropatia diabètica, així com l'estudi dels diferents mediadors del Fracàs Renal Agut en el context de noxes diferent

IP: Maria Jose Soler Romeo, Concepció Jacobs Cachá

Projects

Creación de un método de referencia para detectar Apo-lb por espectrometría de masas dirigida y validación clínica de su potencial como biomarcadore para el síndrome nefrótico idiopático

IP: Concepció Jacobs Cachá
Collaborators: Yolanda Villena Ortiz, Joan López Hellin, Mireia Salvadó Pau, Carmen Llorens Cebriá
Funding agency: Instituto de Salud Carlos III
Funding: 71250
Reference: PI24/01573
Duration: 01/01/2025 - 31/12/2027

ESTUDIO DE LA ENDOCITOSIS MEDIADA POR CUBILINA DE PROTEOFORMAS DE APOA-I EN ORGANOIDES RENALES HUMANOS

IP: Concepció Jacobs Cachá
Collaborators: Miriam Izquierdo Sans
Funding agency: Sociedad Española de Nefrología (S.E.N.)
Funding: 6000
Reference: SEN/AYUDAS OTROS CENTROS/2023/JACOBS
Duration: 01/09/2023 - 30/11/2023

Optimización del test de deposición ex vivo de C5b9 para monitorizar la actividad y la respuesta al tratamiento en SHUa y otras glomerulopatías complejas

IP: Concepció Jacobs Cachá
Collaborators: Optimización del test de deposición ex vivo de C5b9 para monitorizar la actividad y la respuesta al tratamiento en SHUa y otras , Natalia Ramos Terrades, Joana Sellarés Roig, Carmen Llorens Cebriá, Mercedes López González, Janire Perurena Prieto
Funding agency: Sociedad Española de Nefrología (S.E.N.)
Funding: 24000
Reference: SENEFRO/PROJECTES/2023/JACOBS
Duration: 23/12/2023 - 22/12/2025

Project-COMFORT: Patient-Centric blOod saMpling FOr impRoved healThcare

IP: Simon Schwartz Navarro
Collaborators: Roser Ferrer Costa, Pere Soler Palacín, Concepció Jacobs Cachá
Funding agency: EUROPEAN COMMISSION
Funding: 427263.5
Reference: COMFORT- HE--JU-IHI-2023-04
Duration: 01/11/2024 - 30/04/2028

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The new system, made of cellulose and chitosan, enables sustained release of docetaxel and has demonstrated antitumor activity in preclinical models of ovarian cancer and glioblastoma.

Related professionals

María Escribano Cebrián

María Escribano Cebrián

Predoctoral researcher
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more
Claudia Meza Burgos

Claudia Meza Burgos

Research technician
Stroke research
Read more
Fernando Lozano Palacio

Fernando Lozano Palacio

Postdoctoral researcher
Biomedical Research in Urology
Read more
Estibaliz Saez de Gordoa Elizalde

Estibaliz Saez de Gordoa Elizalde

Predoctoral researcher
Neuroradiology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.